ClinicalTrials.govpublic full text
Trial of Motexafin Gadolinium and Pemetrexed (Alimta®) for Second Line Treatment in Patients With Non-Small Cell Lung Cancer
non-small cell lung carcinoma, non small cell lung cancer, lung cancer, metastatic lung cancer, inoperable lung cancer, advanced lung cancer, large cell lung cancer, adenocarcinoma, lung, squamous cell carcinoma, lung, squamous cell lung cancer, large cell carcinoma, lung, cancer of the lung
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 825481
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.